We describe a unique new collaboration which allows linkage of administrative databases in Southern Israel, and hence ascertain risk/safety of prescription drugs in pregnancy. The advantages of this system include availibilty of rigorous data confounders, solid data on maternal conditions for which the drug is given, ability to capture all cases of elective abortions and not just live births, and ability to construct drug doses.
|Number of pages||3|
|Journal||Current Drug Safety|
|State||Published - 9 Feb 2011|
ASJC Scopus subject areas
- Pharmacology (medical)